Erythropoietin as an antiapoptotic, tissue-protective cytokine. (Q35831214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Erythropoietin as an antiapoptotic, tissue-protective cytokine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Michael Brines

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Ghezzi P

series ordinal

1

1 reference

10 August 2017

Brines M

series ordinal

2

1 reference

10 August 2017

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

11 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

S37-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401450

30 December 2019

exact match

0 references

cites work

HIF-1 and mechanisms of hypoxia sensing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

HIF and oxygen sensing; as important to life as the air we breathe?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, [...]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin: a candidate compound for neuroprotection in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Structural design and molecular evolution of a cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Signal transduction in the erythropoietin receptor system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Immunohistochemical localization of erythropoietin and its receptor in the developing human brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and neuroprotective molecules by microglial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

The phosphatidylserine receptor: a crucial molecular switch?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Human CD14 mediates recognition and phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Apoptosis. Phagocytic docking without shocking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Production of proinflammatory cytokines by resident tissue macrophages after phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin improves place learning in fimbria-fornix-transected rats and modifies the search pattern of normal rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin induces changes in gene expression in PC-12 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

ISSLS prize winner: Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin protects against ischaemic acute renal injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Effect of chronic and short-term erythropoietin treatment on random flap survival in rats: an experimental study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin and VEGF exhibit equal angiogenic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Effects of erythropoietin on neuronal activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

In vivo evidence that erythropoietin protects neurons from ischemic damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Potential neuroprotective benefits of erythropoietin during experimental hypothermic circulatory arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Erythropoietin both protects from and reverses experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401450

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15243580%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference